Epigenomics (EPGNY) Stock Price, News & Analysis

Company Overview

Epigenomics AG is a molecular diagnostics company headquartered in Berlin, Germany. The company develops diagnostic tests based on DNA methylation, an epigenetic process that can help identify disease-associated changes in biological samples.

Its best-known product is Epi proColon, a blood-based test designed to detect methylated Septin9 DNA associated with colorectal cancer. The test was developed as a noninvasive screening option for people who may be unwilling or unable to complete conventional screening procedures. Epigenomics has also pursued additional methylation-based diagnostic applications, including tests for other cancers.

Epigenomics has historically served healthcare markets in Europe and the United States through regulatory approvals, commercial partnerships, and direct business activities. The company was founded in 1998 and has focused its research and development efforts on translating epigenetic biomarkers into clinically useful diagnostic products.

Key Stats

• Today's Range: $2.39 to $2.39
• 50-Day Range: $2.39 to $2.39
• 52-Week Range: $2.01 to $2.39
• Volume: N/A
• Average Volume: 100 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Life Sciences Tools & Services
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: OTCMKTS:EPGNY
• CIK: N/A
• Web: www.epigenomics.com
• Phone: (493) 024-3450
• Fax: N/A
• Employees: 32
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A